Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.
Morrissey
I
I
Maher
K
K
Hawser
S
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D005060:Europe; D006801:Humans; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000494:pharmacology*; D013290:Streptococcal Infections / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000187:drug effects* / Q000302:isolation & purification; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification; D014481:United States
D000900:Anti-Bacterial Agents; D011743:Pyrimidines; C486448:iclaprim